{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "f4ac0609-623f-48bf-bbfb-d37972ad5271", "code": "L04AA10", "comments": "ATC|ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|IMMUNOSUPPRESSANTS|IMMUNOSUPPRESSANTS|Selective immunosuppressants|sirolimus", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=L04AA10&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "5bdb1b6b-1acb-4394-b839-2b4fbb9d78a5", "code": "N0000175624", "comments": "Cellular or Molecular Interactions [MoA]|Enzyme Interactions [MoA]|Enzyme Inhibitors [MoA]|Kinase Inhibitors [MoA]|Protein Kinase Inhibitors [MoA]|BRAF Serine/Threonine Kinase Inhibitors [MoA]|mTOR Inhibitors [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175624", "code_system": "NDF-RT", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "d36c9f70-6689-47b4-a149-82b75e27ca4a", "code": "N0000175625", "comments": "Established Pharmacologic Class [EPC]|mTOR Inhibitor Immunosuppressant [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175625", "code_system": "NDF-RT", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "afc156fd-6675-41d1-92d5-322536392bda", "code": "N0000175550", "comments": "Physiological Effects [PE]|Generalized Systemic Effects [PE]|Immunologic Activity Alteration [PE]|Decreased Immunologic Activity [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175550", "code_system": "NDF-RT", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "1c176c93-9e13-4cce-ad5a-596ca9127104", "code": "QL04AA10", "comments": "VATC|IMMUNOSUPPRESSANTS|IMMUNOSUPPRESSANTS|Selective immunosuppressants|sirolimus", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QL04AA10&showdescription=yes", "code_system": "WHO-VATC", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "ee0dca5c-4ff9-4936-8dda-214399e36176", "code": "53123-88-9", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=53123-88-9", "code_system": "CAS", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf", "6b21611c-5b2a-4bb8-bb45-42e053e0c86b" ] }, { "uuid": "79b36931-a412-4b74-ae09-b11e8b9ec89b", "code": "C1212", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1212", "code_system": "NCI_THESAURUS", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "97403272-794b-4901-9924-c92eccf66561", "code": "NBK548028", "comments": "LiverTox|Immunomodulatory|Rejection|mTor inhibitor", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548028/", "code_system": "LIVERTOX", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "1793d9c7-4e8e-46f4-baa5-8a300e6ed591", "code": "D020123", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68020123", "code_system": "MESH", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "d649ea6a-9d10-499b-a96e-ea50ab2482c0", "code": "SIROLIMUS", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Sirolimus", "code_system": "WIKIPEDIA", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "ca9ad58f-effe-4d51-b89b-c992de9a8bba", "code": "RAPAMUNE (AUTHORIZED: GRAFT REJECTION)", "comments": "EMA EPAR|BODY PROCESSES|IMMUNE SYSTEM PROCESSES|IMMUNE SYSTEM PROCESSES|TRANSPLANTATION IMMUNOLOGY|HOST VS. GRAFT REACTION|GRAFT REJECTION", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000273/human_med_001010.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "696206fc-bc84-4ddf-a9ff-015dbd2e19a3", "code": "7104", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=7104", "code_system": "INN", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "f11b2956-f0fd-421a-8a2f-3e7fcc610855", "code": "RAPAMUNE (AUTHORIZED: KINDEY TRANSPLANTATION)", "comments": "EMA EPAR|ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT|THERAPEUTIC TECHNIQUES|RENAL REPLACEMENT THERAPY|KIDNEY TRANSPLANTATION", "type": "PRIMARY", "url": "http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000273/human_med_001010.jsp&mid=WC0b01ac058001d124", "code_system": "EMA ASSESSMENT REPORTS", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "2b869830-4d38-40b4-87f7-e5e2c26d4b11", "code": "6031", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6031", "code_system": "IUPHAR", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "a872cf9e-c370-4ce0-91f9-c71aff2937c3", "code": "35302", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/35302/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "19c9ab1e-885c-4586-b981-ad9c288e584b", "code": "m9502", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m9502?q=authorize", "code_system": "MERCK INDEX", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "dd441889-7c36-439b-b6cc-f767e4ff8d7d", "code": "DB00877", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00877", "code_system": "DRUG BANK", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "62e2799d-15ef-4bd7-88e0-be0835f25abd", "code": "SUB10537MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "e58a02b2-9277-42f6-8744-358237d8f16a", "code": "21 CFR 862.3840", "comments": "PART 862 -- CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES|Subpart D--Clinical Toxicology Test Systems|Sec. 862.3840 Sirolimus test system.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=862.3840", "code_system": "CFR", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "91745dab-6350-4ccf-8e4e-c8b89ae81bf9", "code": "CHEMBL413", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413", "code_system": "ChEMBL", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "dbae84dd-be01-4d37-89d5-bcfabd1ab6db", "code": "S01XA23", "comments": "ATC|SENSORY ORGANS|OPHTHALMOLOGICALS|OTHER OPHTHALMOLOGICALS|Other ophthalmologicals|sirolimus", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=S01XA23&showdescription=yes", "code_system": "WHO-ATC", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "c0f55826-a92f-4e5b-aee6-cc3b70f3ad14", "code": "5284616", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5284616", "code_system": "PUBCHEM", "references": [ "7b71adb8-be2c-477e-8d70-4c7e0faa26bf" ] }, { "uuid": "e4fe3294-c9e6-416e-b040-fd495831e23b", "code": "RAPALIMUS", "comments": "APPROVED JULY 2014", "type": "PRIMARY", "url": "https://www.pmda.go.jp/files/000209869.pdf", "code_system": "JAPANESE REVIEW", "references": [ "9be2ee2a-cc9d-33a9-6504-1db7bda52464" ] }, { "uuid": "abfe045b-6bf3-480a-777f-e6d7629c4f6e", "code": "7284", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/7284", "code_system": "HSDB", "references": [ "f5ca6a95-391a-5a8b-46c1-eb397e83fb7f" ] }, { "uuid": "f2b9b2b3-97cc-78db-9c54-0c3199059bd2", "code": "DTXSID5023582", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID5023582", "code_system": "EPA CompTox", "references": [ "6b2ad326-7ce8-8384-404a-f2079d75cecc" ] }, { "uuid": "02311340-c2f7-3ecd-56ec-f0bd5edc9042", "code": "434114", "comments": "ORPHAN DRUG|Designated|Treatment of lymphangioleiomyomatosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=434114", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "629f90fc-f4b1-f8b1-c422-9c520eca333d", "code": "184304", "comments": "ORPHAN DRUG|Designated|Prevention of arteriovenous(AV) fistula or AV graft failure in patients with end stage renal disease, receiving hemodialysis or preparing for hemodialysis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=184304", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "65ed3b86-788d-2827-2ac0-f2bcf35a50cf", "code": "237007", "comments": "ORPHAN DRUG|Designated|Treatment of tuberous sclerosis complex", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=237007", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "29ac2b46-9cc0-0315-cb31-9a1d90493592", "code": "327210", "comments": "ORPHAN DRUG|Designated|Treatment of chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and non-infectious, uveitis affecting the posterior of the eye (NICUPS).", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=327210", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "95d367a5-9b01-444b-5d7f-857dd74d0216", "code": "391013", "comments": "ORPHAN DRUG|Designated|Treatment of pachyonychia congenita", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=391013", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "c4867586-addc-16f1-c1df-450736bc9f7b", "code": "508515", "comments": "ORPHAN DRUG|Designated|Treatment of facial angiofibromas (FA) associated with tuberous sclerosis complex (TSC).", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=508515", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "069db4ed-33b8-1420-7fc6-d185dc898692", "code": "524916", "comments": "ORPHAN DRUG|Designated|Treatment of beta-thalassemia.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=524916", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "f3c59148-7c8a-dea9-f598-9e2d6da5cab8", "code": "555516", "comments": "ORPHAN DRUG|Designated|Treatment of tuberous sclerosis complex-related facial angiofibromas", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=555516", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "48eb4a60-ecd9-649c-e777-d6fe610a3bea", "code": "379312", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of lymphangioleiomyomatosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=379312", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "c45e49fd-a1b2-2e98-b28f-65193a58b53a", "code": "628918", "comments": "ORPHAN DRUG|Designated|Treatment of sickle cell disease", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=628918", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "aaa4c022-97c6-6332-772d-8ea9072791d5", "code": "540516", "comments": "ORPHAN DRUG|Designated|Treatment of pulmonary arterial hypertention", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=540516", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "29f1f6b1-a3e5-189a-d624-50c183c0b0bd", "code": "C261", "comments": "Pharmacologic Substance[C1909]|Anti-Infective Agent[C254]|Antibiotic[C258]|Macrolide Antibiotic", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C261", "code_system": "NCI_THESAURUS", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "5cc3f7cf-dd5d-9df8-6b18-6b1de1fd9526", "code": "C574", "comments": "Pharmacologic Substance[C1909]|Immunotherapeutic Agent[C308]|Immunosuppressant", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C574", "code_system": "NCI_THESAURUS", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "bdd26e6c-df37-d7c6-7436-f39272daefbb", "code": "469915", "comments": "ORPHAN DRUG|Designated|Treatment of angiosarcoma", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=469915", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "6a1c12c0-c775-dd26-8482-57d287b7d10b", "code": "N0000175605", "comments": "Established Pharmacologic Class [EPC]|Kinase Inhibitor [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175605", "code_system": "NDF-RT", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "b5ce6399-d985-9706-eae2-a3525638634b", "code": "678319", "comments": "ORPHAN DRUG|Designated|Treatment of familial adenomatous polyposis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=678319", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "2dcba2f1-1b1f-71f1-27bb-abc0bfd6f51b", "code": "698619", "comments": "ORPHAN DRUG|Designated|Treatment of tuberous sclerosis complex", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=698619", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "653e3674-c099-8715-0aa4-d03de166e5c7", "code": "EU/3/17/1910", "comments": "EU ORPHAN DRUG|Positive|Treatment of tuberous sclerosis", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3171910", "code_system": "EU-Orphan Drug", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "b4c51c17-aeb2-5a18-6181-40eee1563f14", "code": "Sirolimus", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM740/", "code_system": "LACTMED", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "cdcc1ffa-6958-43f1-b989-2c99d20453ba", "code": "W36ZG6FT64", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "156c942f-28c0-5004-1337-60ecfff3a002", "code": "453114", "comments": "ORPHAN DRUG|Designated|Treatment of lymphangioleiomyomatosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=453114", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "e549a202-0564-2350-aca8-f7b1f3a3772f", "code": "2446", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/2446", "code_system": "DRUG CENTRAL", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "5ec6689c-3867-1bc4-bda0-014df7e54de1", "code": "828521", "comments": "ORPHAN DRUG|Designated|Treatment of Sarcoidosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=828521", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "8ada038f-f493-bc8d-c0e8-983da0fd6e62", "code": "9168", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:9168", "code_system": "CHEBI", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "cda4a46c-4e1a-c491-60e1-fcc1b9140e4e", "code": "829421", "comments": "ORPHAN DRUG|Designated|Treatment of Lymphatic Malformations", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=829421", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "4eb14898-624f-3ae2-4847-159d3bb4784f", "code": "1612765", "type": "PRIMARY", "url": "https://store.usp.org/product/1612765", "code_system": "RS_ITEM_NUM", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "515b95b6-77ef-14bb-4ad4-5e61691e0a61", "code": "DD-70", "type": "PRIMARY", "url": "https://searchusan.ama-assn.org/finder/usan/search/DD-70/relevant/1/", "code_system": "USAN", "references": [ "7b5b0247-6a3e-ebe7-549b-c849e69d3b4a" ] }, { "uuid": "274f144c-8085-c36f-9b34-d5491de1ce5d", "code": "W36ZG6FT64", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=W36ZG6FT64", "code_system": "DAILYMED", "references": [ "51390116-05c0-e644-ac07-e5238a2bf4a0" ] }, { "uuid": "ca7acc1a-257e-a005-1d0a-372287e65ca2", "code": "833821", "comments": "ORPHAN DRUG|Designated|Treatment of Bronchiolitis Obliterans Syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=833821", "code_system": "FDA ORPHAN DRUG", "references": [ "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2" ] }, { "uuid": "61787601-53cd-9353-2b24-e01a9c640852", "code": "100000089170", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "fbd767b9-6506-71a5-1a8c-6d903eaa9aa8" ] }, { "uuid": "057eb2a5-bab0-1fb1-7d56-1a31d0ed2682", "code": "568416", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of angiofibroma associated with tuberous sclerosis", "codeText": "ORPHAN DRUG|Designated/Approved|Treatment of angiofibroma associated with tuberous sclerosis", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=568416", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "40678e51-cc13-5be8-3a36-a99dc93bd014", "code": "226080", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=226080", "code_system": "NSC", "references": [ "6f1f39b6-4fcb-202d-4805-e4c59fcd020e" ] }, { "uuid": "0dde26a5-9afc-559b-f990-d92915ca4ea7", "code": "616217", "comments": "ORPHAN DRUG|Designated/Approved|Treatment of perivascular epithelioid cell tumors (PEComa)", "codeText": "ORPHAN DRUG|Designated/Approved|Treatment of perivascular epithelioid cell tumors (PEComa)", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=616217", "code_system": "FDA ORPHAN DRUG" } ], "substance_class": "chemical", "references": [ { "uuid": "7b8d2c60-c07c-e679-ce9f-c75d049c0c93", "citation": "Desai, N., O. D'Cruz, and V. Trieu. \"Combination Regimens of nab-Rapamycin (ABI-009) Effective Against MDA-MB-231 Breast-Tumor Xenografts.\" (2009): 6106-6106.", "url": "https://cancerres.aacrjournals.org/content/69/24_Supplement/6106.short", "doc_type": "MEETING ABSTRACT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2ca95896-bc2c-4e08-a59b-f34350caead1", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "189c1476-4751-46a6-88ff-c56e5c2f13be", "citation": "MERCK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "citation": "MERCK INDEX", "doc_type": "MERCK INDEX", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "39ade78c-c044-4701-b33f-7c839c6b700b", "citation": "ATC CODE 2009", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "de142a70-dfcd-4235-8531-42e9097860f3", "citation": "WHO 2009", "doc_type": "INN", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d45d2971-9722-4394-8fd6-f2979271ccf3", "citation": "INN 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5cf98eb8-23e4-464c-a94a-a2197c33b6c3", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b9a9b43a-51ca-4f4a-9cba-0a3a951a44f9", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "36eeb0a4-9c4d-4d98-8390-6cbedd8f73d1", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e787844a-521e-403a-ae4d-f8214a65a269", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2b4c717b-c5b7-45ed-b39b-9698b2fca01a", "citation": "EMA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "74b19bec-4706-4a76-9ece-1bbf4ab4a225", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f6c73a97-bdf3-4b53-82bb-bf28f81eb573", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fe1350aa-8032-499a-9273-e233dac03a33", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7b71adb8-be2c-477e-8d70-4c7e0faa26bf", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493390521000, "tags": [ "NOMEN" ] }, { "uuid": "97ee4a1a-30cc-4901-be7f-7e69c19c9d0b", "citation": "Trends in Pharmacological Sciences, November 2014, Vol. 35, No. 11 604-620", "url": "Trends in Pharmacological Sciences, November 2014, Vol. 35, No. 11 604-620", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "e170cd14-61af-45b2-93b8-f25f37715567", "citation": "SRS import [W36ZG6FT64]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=W36ZG6FT64", "doc_type": "SRS", "public_domain": true, "document_date": 1493390521000, "tags": [ "NOMEN" ] }, { "uuid": "b5408740-2b6c-4d3d-8fa9-008e16b4f91e", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "42a862a5-82c0-4976-a490-abeada4572fc", "citation": "SIROLIMUS [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "76934891-d9b8-450a-828c-2b5a5b026d17", "citation": "SIROLIMUS [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "11aeafbf-e543-4aec-9421-f7c7a05ddbf2", "citation": "SIROLIMUS [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "76ee5e3f-424c-4987-a8c5-3f14bd3cda73", "citation": "SIROLIMUS [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "bde229d1-a903-49e3-9d10-059c774b09f5", "citation": "RAPAMYCIN [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "3fa6945f-d253-42ae-bae5-9163062b6d83", "citation": "SIROLIMUS [EMA EPAR]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "a6ae1e2a-0db9-41e0-9a6b-aaa0b9f2a469", "citation": "SIROLIMUS [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8d5b15d6-6813-4748-bc32-b19332568a36", "citation": "SIROLIMUS [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "55ebbf79-4c31-4567-abab-791f324c4010", "citation": "SIROLIMUS [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "4c5fd4e1-762f-2279-e7d6-9e8989b29fc1", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "9be2ee2a-cc9d-33a9-6504-1db7bda52464", "citation": "https://www.pmda.go.jp/files/000209869.pdf", "doc_type": "JAN", "public_domain": true }, { "uuid": "f5ca6a95-391a-5a8b-46c1-eb397e83fb7f", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+53123-88-9", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6b2ad326-7ce8-8384-404a-f2079d75cecc", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=53123-88-9", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "dfc0e19e-c72c-eb85-0a5c-0ade9cf51b70", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+53123-88-9", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "52d6a9e3-0538-4c25-97f3-a2afd60ac98d", "citation": "https://pubs.rsc.org/en/content/getauthorversionpdf/c4np00064a", "url": "https://pubs.rsc.org/en/content/getauthorversionpdf/c4np00064a", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ab5a3b26-ea17-6520-4a0f-30f02b8d46a2", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "e0516af2-1aa9-651f-94fe-ff524bd5cf4f", "citation": "https://ichgcp.net/clinical-trials-registry/NCT02634931", "url": "https://ichgcp.net/clinical-trials-registry/NCT02634931", "doc_type": "CLINICALTRIALS", "public_domain": true }, { "uuid": "01f5b1dd-34b4-99ee-ce63-e66b120d0703", "citation": "COMPANY WEB SITE (TYME INC.)", "url": "https://www.tymeinc.com/pipeline/sm-88-overview/default.aspx", "doc_type": "WEB PAGE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6b21611c-5b2a-4bb8-bb45-42e053e0c86b", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "7b5b0247-6a3e-ebe7-549b-c849e69d3b4a", "citation": "USAD COUN", "doc_type": "USANCOUN", "public_domain": true }, { "uuid": "78ae6c72-3610-a303-ead3-dbc8703846a6", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021083s067,021110s085lbl.pdf", "doc_type": "FDA APPROVED DRUG LABEL", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "41696263-17ca-4ea8-9372-4f2c1a9e3f25", "citation": "INN Proposed List 116", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL116.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5099ccef-01d3-86b4-9943-6390cfa7daf0", "citation": "Ferron, Geraldine M., and William J. Jusko. \"Species differences in sirolimus stability in humans, rabbits, and rats.\" Drug metabolism and disposition 26.1 (1998): 83-84.", "url": "https://dmd.aspetjournals.org/content/dmd/26/1/83.full.pdf", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4955268a-f268-4c73-85dd-a9db0dc0591d", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213478s000lbl.pdf", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213478s000lbl.pdf", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7b874f6b-b897-4607-b2b6-ca26e1157fa8", "citation": "EP 10.8", "doc_type": "EP", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "40d9209d-3223-3a7a-648a-e8e266b4a282", "citation": "USP-RS", "doc_type": "USPNF", "public_domain": true }, { "uuid": "2a330545-fb2c-4cdd-826a-03a0b1fed27d", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213312Orig1s000Corrected_lbl.pdf", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213312Orig1s000Corrected_lbl.pdf", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6f1f39b6-4fcb-202d-4805-e4c59fcd020e", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "d8350819-00ea-1cc4-c465-cc7f806778c0", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "85f5d27e-f811-4c37-8e2a-9b0797f8101c", "citation": "Gallant-Haidner, Heather L., et al. \"Pharmacokinetics and metabolism of sirolimus.\" Therapeutic drug monitoring 22.1 (2000): 31-35.", "url": "https://journals.lww.com/drug-monitoring/Fulltext/2000/02000/Pharmacokinetics_and_Metabolism_of_Sirolimus.6.aspx", "doc_type": "JA", "public_domain": true }, { "uuid": "51390116-05c0-e644-ac07-e5238a2bf4a0", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "fbd767b9-6506-71a5-1a8c-6d903eaa9aa8", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "e6f028bf-fd40-45ec-8629-12eeb95753ae", "id": "e6f028bf-fd40-45ec-8629-12eeb95753ae", "molfile": "\n CDK 08302404492D\n\n 68 71 0 0 1 0 0 0 0 0999 V2000\n 28.3872 -7.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3872 -8.6272 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 29.7581 -6.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7581 -4.7036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4763 -4.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.1889 -13.2992 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 33.8392 -3.9393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 40.5362 -14.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8574 -10.9592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1290 -3.9236 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 29.7345 -9.4229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 39.2046 -11.7392 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 37.8653 -9.3992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.1865 -4.7193 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 36.5181 -7.0593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.1708 -6.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.5362 -15.6391 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 36.5181 -8.6192 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 32.4290 -14.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.0818 -13.3308 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 27.0400 -6.2872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 27.0400 -9.4229 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 31.0818 -11.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1054 -7.0672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7345 -10.9908 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 32.4683 -6.2793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 41.9780 -3.9393 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 36.5574 -3.9236 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 41.8834 -13.2835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4211 -15.6707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7345 -7.8392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 39.1810 -16.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.6307 -4.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8653 -6.2636 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 37.9126 -4.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 41.9780 -2.3636 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 33.7683 -16.4507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.2755 -3.9236 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0\n 33.7526 -18.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.0999 -18.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.4471 -18.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.0400 -10.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.6307 -1.5757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8417 -14.0635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3872 -3.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.5519 -10.9435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3872 -11.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 38.2671 -17.9791 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 39.2598 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7266 -14.1107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 43.3252 -4.7193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 36.4944 -11.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 43.3409 -1.5757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1290 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 33.7763 -13.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 41.8834 -16.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.1629 -9.3835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.5417 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.6848 -8.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.4865 -13.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 43.3173 -6.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3636 -13.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.1653 -19.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.4029 -2.3400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7738 -1.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4763 -3.1436 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 35.0363 -2.9322 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 31.0818 -10.1872 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 1 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 10 1 0 0 0 0\n 6 12 1 0 0 0 0\n 7 5 1 0 0 0 0\n 8 6 1 0 0 0 0\n 9 13 2 0 0 0 0\n 10 4 1 0 0 0 0\n 11 2 1 0 0 0 0\n 12 9 1 0 0 0 0\n 13 18 1 0 0 0 0\n 14 7 1 0 0 0 0\n 15 16 1 0 0 0 0\n 16 14 1 0 0 0 0\n 17 32 1 0 0 0 0\n 18 15 1 0 0 0 0\n 19 20 1 0 0 0 0\n 20 23 1 0 0 0 0\n 21 1 2 0 0 0 0\n 22 2 1 0 0 0 0\n 23 25 1 0 0 0 0\n 24 3 2 0 0 0 0\n 25 11 1 0 0 0 0\n 26 5 2 0 0 0 0\n 27 33 1 0 0 0 0\n 28 14 1 0 0 0 0\n 29 8 2 0 0 0 0\n 19 30 2 0 0 0 0\n 2 31 1 1 0 0 0\n 32 48 1 0 0 0 0\n 33 38 1 0 0 0 0\n 34 15 2 0 0 0 0\n 35 28 1 0 0 0 0\n 36 43 1 0 0 0 0\n 37 30 1 0 0 0 0\n 38 35 1 6 0 0 0\n 37 39 2 0 0 0 0\n 40 39 1 0 0 0 0\n 40 41 2 0 0 0 0\n 42 22 1 0 0 0 0\n 43 49 1 0 0 0 0\n 6 44 1 6 0 0 0\n 45 4 1 0 0 0 0\n 12 46 1 1 0 0 0\n 47 42 1 0 0 0 0\n 48 41 1 0 0 0 0\n 49 38 1 0 0 0 0\n 20 50 1 1 0 0 0\n 27 51 1 6 0 0 0\n 52 9 1 0 0 0 0\n 36 53 1 1 0 0 0\n 54 10 1 0 0 0 0\n 55 19 1 0 0 0 0\n 17 56 1 6 0 0 0\n 18 57 1 1 0 0 0\n 28 58 1 6 0 0 0\n 22 59 1 1 0 0 0\n 60 44 1 0 0 0 0\n 61 51 1 0 0 0 0\n 62 50 1 0 0 0 0\n 48 63 1 6 0 0 0\n 64 45 1 0 0 0 0\n 65 64 1 0 0 0 0\n 10 66 1 6 0 0 0\n 14 67 1 1 0 0 0\n 25 68 1 1 0 0 0\n 25 47 1 0 0 0 0\n 54 65 1 0 0 0 0\n 27 36 1 0 0 0 0\n 8 17 1 0 0 0 0\nM END", "smiles": "C[C@@H]1/C=C/C=C/C=C(\\C)/[C@H](C[C@]2([H])CC[C@@H](C)[C@@](C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)/C=C(\\C)/[C@H]([C@H](C(=O)[C@H](C)C1)OC)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)(O)O2)OC", "formula": "C51H79NO13", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "aa5253d4-27ef-425f-8cc0-649525c1b634" }, "defined_stereo": 15, "ez_centers": 4, "molecular_weight": "914.1738", "optical_activity": "UNSPECIFIED", "stereo_centers": 15 } ], "definition_level": "COMPLETE", "uuid": "e698b173-a965-40b6-b560-60e0dccdaa83", "version": "108", "structure": { "id": "3cfd6e92-68a1-4137-9884-9fccbdef42bd", "molfile": "\n JSDraw208302404492D\n\n 68 71 0 0 1 0 0 V2000\n 28.3872 -7.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3872 -8.6272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7581 -6.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7581 -4.7036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4763 -4.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.1889 -13.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 33.8392 -3.9393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 40.5362 -14.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8574 -10.9592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1290 -3.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7345 -9.4229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 39.2046 -11.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8653 -9.3992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.1865 -4.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.5181 -7.0593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.1708 -6.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.5362 -15.6391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.5181 -8.6192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4290 -14.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.0818 -13.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.0400 -6.2872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 27.0400 -9.4229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.0818 -11.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1054 -7.0672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7345 -10.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4683 -6.2793 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 41.9780 -3.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.5574 -3.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 41.8834 -13.2835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4211 -15.6707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7345 -7.8392 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 39.1810 -16.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.6307 -4.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8653 -6.2636 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 37.9126 -4.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 41.9780 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 33.7683 -16.4507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.2755 -3.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 33.7526 -18.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.0999 -18.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.4471 -18.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 27.0400 -10.9908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.6307 -1.5757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 37.8417 -14.0635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3872 -3.9236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 40.5519 -10.9435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3872 -11.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 38.2671 -17.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.2598 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7266 -14.1107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 43.3252 -4.7193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 36.4944 -11.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 43.3409 -1.5757 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 31.1290 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 33.7763 -13.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 41.8834 -16.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 35.1629 -9.3835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.5417 -2.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 25.6848 -8.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 36.4865 -13.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 43.3173 -6.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.3636 -13.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 39.1653 -19.5470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 28.4029 -2.3400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 29.7738 -1.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 32.4763 -3.1436 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 35.0363 -2.9322 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 31.0818 -10.1872 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 1 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 10 1 0 0 0 0\n 6 12 1 0 0 0 0\n 7 5 1 0 0 0 0\n 8 6 1 0 0 0 0\n 9 13 2 0 0 0 0\n 10 4 1 0 0 0 0\n 11 2 1 0 0 0 0\n 12 9 1 0 0 0 0\n 13 18 1 0 0 0 0\n 14 7 1 0 0 0 0\n 15 16 1 0 0 0 0\n 16 14 1 0 0 0 0\n 17 32 1 0 0 0 0\n 18 15 1 0 0 0 0\n 19 20 1 0 0 0 0\n 20 23 1 0 0 0 0\n 21 1 2 0 0 0 0\n 22 2 1 0 0 0 0\n 23 25 1 0 0 0 0\n 24 3 2 0 0 0 0\n 25 11 1 0 0 0 0\n 26 5 2 0 0 0 0\n 27 33 1 0 0 0 0\n 28 14 1 0 0 0 0\n 29 8 2 0 0 0 0\n 30 19 2 0 0 0 0\n 2 31 1 1 0 0 0\n 32 48 1 0 0 0 0\n 33 38 1 0 0 0 0\n 34 15 2 0 0 0 0\n 35 28 1 0 0 0 0\n 36 43 1 0 0 0 0\n 37 30 1 0 0 0 0\n 38 35 1 6 0 0 0\n 39 37 2 0 0 0 0\n 40 39 1 0 0 0 0\n 41 40 2 0 0 0 0\n 42 22 1 0 0 0 0\n 43 49 1 0 0 0 0\n 6 44 1 6 0 0 0\n 45 4 1 0 0 0 0\n 12 46 1 1 0 0 0\n 47 42 1 0 0 0 0\n 48 41 1 0 0 0 0\n 49 38 1 0 0 0 0\n 20 50 1 1 0 0 0\n 27 51 1 6 0 0 0\n 52 9 1 0 0 0 0\n 36 53 1 1 0 0 0\n 54 10 1 0 0 0 0\n 55 19 1 0 0 0 0\n 17 56 1 6 0 0 0\n 18 57 1 1 0 0 0\n 28 58 1 6 0 0 0\n 22 59 1 1 0 0 0\n 60 44 1 0 0 0 0\n 61 51 1 0 0 0 0\n 62 50 1 0 0 0 0\n 48 63 1 6 0 0 0\n 64 45 1 0 0 0 0\n 65 64 1 0 0 0 0\n 10 66 1 6 0 0 0\n 14 67 1 1 0 0 0\n 25 68 1 1 0 0 0\n 25 47 1 0 0 0 0\n 54 65 1 0 0 0 0\n 27 36 1 0 0 0 0\n 8 17 1 0 0 0 0\nM END", "smiles": "C[C@@H]1/C=C/C=C/C=C(\\C)/[C@H](C[C@]2([H])CC[C@@H](C)[C@@](C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)/C=C(\\C)/[C@H]([C@H](C(=O)[C@H](C)C1)OC)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)(O)O2)OC", "formula": "C51H79NO13", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "defined_stereo": 15, "ez_centers": 4, "molecular_weight": "914.1738", "optical_activity": "( - )", "references": [ "b5408740-2b6c-4d3d-8fa9-008e16b4f91e", "e170cd14-61af-45b2-93b8-f25f37715567", "41696263-17ca-4ea8-9372-4f2c1a9e3f25" ], "stereo_centers": 15 }, "unii": "W36ZG6FT64", "relationships": [ { "uuid": "5921c518-f0df-41e9-b811-883e0037fefe", "amount": { "uuid": "2c9bb507-9603-49e4-b0b7-bb02dd856579" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "37671e70-30c0-4d09-b2dc-61efc02a18c7", "refuuid": "e698b173-a965-40b6-b560-60e0dccdaa83", "name": "Sirolimus", "unii": "W36ZG6FT64", "linking_id": "W36ZG6FT64", "ref_pname": "Sirolimus", "substance_class": "reference" } }, { "uuid": "eff7f1ac-55bd-49ae-ad15-ffdbe71dc8a9", "amount": { "uuid": "254b6de6-68d2-458f-a1d7-d7ee05056a03" }, "type": "TRANSPORTER->SUBSTRATE", "references": [ "85f5d27e-f811-4c37-8e2a-9b0797f8101c" ], "related_substance": { "uuid": "808bdda1-52b7-4271-8b5a-5938930ccf7d", "refuuid": "3921aa0b-fd6d-40ec-9c07-d83e5c6f124a", "name": "MULTIDRUG RESISTANCE PROTEIN 1", "unii": "22ES734693", "linking_id": "22ES734693", "ref_pname": "MULTIDRUG RESISTANCE PROTEIN 1", "substance_class": "reference" } }, { "uuid": "95586ad3-67b4-4ef1-81d1-e6899cedacb4", "amount": { "uuid": "639b2b4d-5a97-4ed6-94bd-3a79c0e80dd3" }, "type": "TARGET->INHIBITOR", "references": [ "97ee4a1a-30cc-4901-be7f-7e69c19c9d0b" ], "related_substance": { "uuid": "6fc67ce9-36b9-4428-bb10-746b962c249b", "refuuid": "94b168e2-73ba-4d4c-b733-2b50a84840e9", "name": "SERINE/THREONINE-PROTEIN KINASE MTOR", "unii": "1788PW098Q", "linking_id": "1788PW098Q", "ref_pname": "SERINE/THREONINE-PROTEIN KINASE MTOR", "substance_class": "reference" } }, { "uuid": "fbcbe7e8-3621-4d2a-ae98-d425cd69f5d8", "amount": { "uuid": "0fa90b47-ca3f-4a66-a1c3-45f3189f4bf0" }, "type": "METABOLITE ACTIVE->PARENT", "related_substance": { "uuid": "e72deb7a-afc4-425d-8375-0b4601a58e8b", "refuuid": "9d5b65a7-2bb6-4237-993a-9fce6b7fda78", "name": "NOVOLIMUS", "unii": "2719UAHUA8", "linking_id": "2719UAHUA8", "ref_pname": "NOVOLIMUS" } }, { "uuid": "65b0f84a-ecf2-4b96-923d-4e2f6a2fa884", "amount": { "uuid": "17c55f24-2829-4d3c-aca8-e2b18c857965", "average": 92, "units": "%" }, "comments": "Sirolimus is extensively bound (approximately 92%) to human plasma proteins, mainly serum albumin (97%), α1-acid glycoprotein, and lipoproteins.", "type": "BINDER->LIGAND", "interaction_type": "BINDING", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ], "related_substance": { "uuid": "ad0e89af-b45d-4a6a-b503-c5d62e0c8fd9", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "0a0c12eb-6c14-4c77-8792-f3556ec7e76e", "amount": { "uuid": "1e506f4e-4573-4f8d-8238-965565189b70" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ], "related_substance": { "uuid": "edebadf9-bedc-46ae-bfca-4d9db2cd768d", "refuuid": "4275827d-e329-4907-95b5-7d690692872a", "name": "CYTOCHROME P450 3A4", "unii": "PUO0521HZV", "linking_id": "PUO0521HZV", "ref_pname": "CYTOCHROME P450 3A4", "substance_class": "reference" } }, { "uuid": "70f8c64a-deec-4bc5-836d-f4d8315553d4", "amount": { "uuid": "30e2cc66-8622-4def-a32f-60a4133d5e30", "average": 2.2, "units": "%" }, "qualification": "URINE", "type": "EXCRETED UNCHANGED", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ], "related_substance": { "uuid": "5421532c-b633-4802-9471-772a576df4bc", "refuuid": "e698b173-a965-40b6-b560-60e0dccdaa83", "name": "Sirolimus", "unii": "W36ZG6FT64", "linking_id": "W36ZG6FT64", "ref_pname": "Sirolimus", "substance_class": "reference" } }, { "uuid": "72732ef3-a616-4b33-9194-f014858578bf", "amount": { "uuid": "2756311d-d20f-4bda-9f85-44bd17b43cec" }, "type": "TARGET->INHIBITOR", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ], "related_substance": { "uuid": "06cbb3c5-6f75-4090-814f-c89a24f45777", "refuuid": "6356484d-c95b-9573-0c69-b8a9300668cb", "name": "IL-4 HUMAN", "unii": "4I7AHS3FPJ", "linking_id": "4I7AHS3FPJ", "ref_pname": "IL-4 HUMAN", "substance_class": "reference" } }, { "uuid": "b0b9dc03-b42d-4524-9710-62513181fb6a", "amount": { "uuid": "93df99dd-d8dc-4a08-99f5-3bcce99614f1" }, "type": "TARGET->INHIBITOR", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ], "related_substance": { "uuid": "19e9b93d-cc1c-41f9-8dd7-094cd50020d9", "refuuid": "1611e7bb-faf8-4456-bcf1-f1e82c5f1140", "name": "HUMAN INTERLEUKIN-2", "unii": "FNO32LO217", "linking_id": "FNO32LO217", "ref_pname": "HUMAN INTERLEUKIN-2", "substance_class": "reference" } }, { "uuid": "a71fdb14-b624-4dc6-b645-5064dcfe30ab", "amount": { "uuid": "ca0b763e-97f2-4a0c-a009-397aa4c56534" }, "type": "TARGET->INHIBITOR", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ], "related_substance": { "uuid": "66a7f1e4-825c-47ce-9983-91a0c9af56de", "refuuid": "17e73429-addd-f815-f423-439039f99b14", "name": "HUMAN IL-15", "unii": "HRJ300HC9W", "linking_id": "HRJ300HC9W", "ref_pname": "HUMAN IL-15", "substance_class": "reference" } }, { "uuid": "c14520ec-4683-4725-8da7-ef9080b15021", "amount": { "uuid": "0a8508ac-eb62-4045-8787-c9f69b695835" }, "type": "IMPURITY->PARENT", "related_substance": { "uuid": "9875bc31-3ca9-4097-a3a2-a32966fff46f", "refuuid": "b886bf82-93e1-4af6-824a-333db870d5a6", "name": "SECORAPAMYCIN A", "unii": "ZVF9AF2S67", "linking_id": "ZVF9AF2S67", "ref_pname": "SECORAPAMYCIN A" } }, { "uuid": "81d587f4-b352-4b7e-a8b2-ebdbc4c665e1", "amount": { "uuid": "63186561-db6a-4ba8-bda0-4a5d711416fc" }, "type": "DERIVATIVE->PARENT", "references": [ "52d6a9e3-0538-4c25-97f3-a2afd60ac98d" ], "related_substance": { "uuid": "6763bdf2-4aec-49cf-b26c-73e1ae5ffeb6", "refuuid": "acc8be75-f8bf-45ce-a4fc-4ba462aa35d7", "name": "OLCOROLIMUS", "unii": "IGL4DTS8F8", "linking_id": "IGL4DTS8F8", "ref_pname": "OLCOROLIMUS", "substance_class": "reference" } }, { "uuid": "e358dfe0-3708-47ff-ae62-67758619ec9a", "amount": { "uuid": "c4a74890-66a5-407f-be17-328744eb6688" }, "type": "PARENT->IMPURITY", "references": [ "7b874f6b-b897-4607-b2b6-ca26e1157fa8" ], "related_substance": { "uuid": "c4b4cae6-6994-4126-841e-79e5163b49e7", "refuuid": "c3be78ca-34b3-40df-8932-b66dab64bc69", "name": "Everolimus", "unii": "9HW64Q8G6G", "linking_id": "9HW64Q8G6G", "ref_pname": "Everolimus", "substance_class": "reference" } }, { "uuid": "b10357f6-386a-47ae-81ab-500a94b4f325", "amount": { "uuid": "bf25d556-1a5b-445e-a28e-7d33bc1d7755" }, "type": "DERIVATIVE->PARENT", "related_substance": { "uuid": "76bbe2d7-a50e-47fb-99f1-b24d585d6a5e", "refuuid": "d4b73b49-543a-47b4-8954-a62c847f3617", "name": "UMIROLIMUS", "unii": "U36PGF65JH", "linking_id": "U36PGF65JH", "ref_pname": "UMIROLIMUS", "substance_class": "reference" } } ], "names": [ { "uuid": "2cf92ae1-62bd-45cc-bcb7-1c1360be98ae", "name": "(-)-Rapamycin", "stdName": "(-)-RAPAMYCIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "6b21611c-5b2a-4bb8-bb45-42e053e0c86b" ], "display_name": false }, { "uuid": "7481d456-9480-4e54-9947-9cd3f4246dee", "name": "(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone", "stdName": "(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34AS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34A-HEXADECAHYDRO-9,27-DIHYDROXY-3-((1R)-2-((1S,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHYL)-10,21-DIMETHOXY-6,8,12,14,20,26-HEXAMETHYL-23,27-EPOXY-3H-PYRIDO(2,1-C)(1,4)OXAAZACYCLOHENTRIACONTINE-1,5,11,28,29(4H,6H,31H)-PENTONE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "6b21611c-5b2a-4bb8-bb45-42e053e0c86b" ], "display_name": false }, { "uuid": "162f9a18-a9a7-47f1-9359-c0b11badab4c", "name": "AY-22989", "stdName": "AY-22989", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "189c1476-4751-46a6-88ff-c56e5c2f13be", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93" ], "display_name": false }, { "uuid": "11ea8a0e-1bfd-e685-c95d-504f0d607201", "name": "EVEROLIMUS IMPURITY A [EP IMPURITY]", "stdName": "EVEROLIMUS IMPURITY A [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7b874f6b-b897-4607-b2b6-ca26e1157fa8" ], "display_name": false }, { "uuid": "a52ae69b-7348-4d7e-b820-30f859e6e4d4", "name": "FYARRO", "stdName": "FYARRO", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "2a330545-fb2c-4cdd-826a-03a0b1fed27d" ], "display_name": false }, { "uuid": "d232c3da-b0bd-4a25-8954-4b177a7f4452", "name": "HYFTOR", "stdName": "HYFTOR", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "4955268a-f268-4c73-85dd-a9db0dc0591d" ], "display_name": false }, { "uuid": "7a8807dd-3c48-4443-84f4-27c94e2dcf17", "name": "L04AA10", "stdName": "L04AA10", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "39ade78c-c044-4701-b33f-7c839c6b700b", "de142a70-dfcd-4235-8531-42e9097860f3" ], "display_name": false }, { "uuid": "56c6ea25-9f13-3844-0794-3ee97f753391", "name": "NAB-RAPAMYCIN COMPONENT RAPAMYCIN", "stdName": "NAB-RAPAMYCIN COMPONENT RAPAMYCIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7b8d2c60-c07c-e679-ce9f-c75d049c0c93" ], "display_name": false }, { "uuid": "8d68a4dc-3a6f-631c-6aef-3d2578d2b0fc", "name": "NPC-12G", "stdName": "NPC-12G", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e0516af2-1aa9-651f-94fe-ff524bd5cf4f" ], "display_name": false }, { "uuid": "52a76138-7b37-4a53-bb2a-2c088d770f5a", "name": "NSC-226080", "stdName": "NSC-226080", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "189c1476-4751-46a6-88ff-c56e5c2f13be", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93" ], "display_name": false }, { "uuid": "7d1c3eb3-9595-418a-83f9-920097de8c5b", "name": "RAPA", "stdName": "RAPA", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "189c1476-4751-46a6-88ff-c56e5c2f13be", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93" ], "display_name": false }, { "uuid": "e342a907-3fad-c8ee-dad2-035870a44383", "name": "RAPALIMUS", "stdName": "RAPALIMUS", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "9be2ee2a-cc9d-33a9-6504-1db7bda52464" ], "display_name": false }, { "uuid": "dcb6461f-43f1-4f94-a6a9-5da951435ed2", "name": "RAPAMUNE", "stdName": "RAPAMUNE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "189c1476-4751-46a6-88ff-c56e5c2f13be", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93" ], "display_name": false }, { "uuid": "abd9ea9c-f214-4961-a240-1bccc4392648", "name": "RAPAMYCIN", "stdName": "RAPAMYCIN", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e787844a-521e-403a-ae4d-f8214a65a269", "bde229d1-a903-49e3-9d10-059c774b09f5", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "2ca95896-bc2c-4e08-a59b-f34350caead1" ], "display_name": false }, { "uuid": "363cf03a-415d-4206-bcec-e1dda37e4f03", "name": "RAPAMYCIN [MI]", "stdName": "RAPAMYCIN [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e787844a-521e-403a-ae4d-f8214a65a269", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93" ], "display_name": false }, { "uuid": "5c003f6c-7351-4d31-a0c5-da128f93accd", "name": "RPM", "stdName": "RPM", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "189c1476-4751-46a6-88ff-c56e5c2f13be", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93" ], "display_name": false }, { "uuid": "ddb474a3-8a89-4482-ad12-d5e19d69c244", "name": "SIROLIMUS [EMA EPAR]", "stdName": "SIROLIMUS [EMA EPAR]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "2b4c717b-c5b7-45ed-b39b-9698b2fca01a" ], "display_name": false }, { "uuid": "573cd6ed-1c16-435a-a435-d809ebb78151", "name": "SIROLIMUS [HSDB]", "stdName": "SIROLIMUS [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "74b19bec-4706-4a76-9ece-1bbf4ab4a225" ], "display_name": false }, { "uuid": "3e18b775-ead5-4fb7-bf18-3c9a2c81544e", "name": "SIROLIMUS [JAN]", "stdName": "SIROLIMUS [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4c5fd4e1-762f-2279-e7d6-9e8989b29fc1" ], "display_name": false }, { "uuid": "f364ef14-51f4-4c66-bb1a-589eeb0cf58a", "name": "SIROLIMUS [MART.]", "stdName": "SIROLIMUS [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "36eeb0a4-9c4d-4d98-8390-6cbedd8f73d1" ], "display_name": false }, { "uuid": "882ed326-ed2e-4227-afb1-9df658f49b0b", "name": "SIROLIMUS [ORANGE BOOK]", "stdName": "SIROLIMUS [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b9a9b43a-51ca-4f4a-9cba-0a3a951a44f9" ], "display_name": false }, { "uuid": "d947eb3b-52bd-45dd-85ec-a158c7c02053", "name": "SIROLIMUS [USAN]", "stdName": "SIROLIMUS [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5cf98eb8-23e4-464c-a94a-a2197c33b6c3" ], "display_name": false }, { "uuid": "a660f5e2-a0cc-bf78-714b-29c19d704eae", "name": "SIROLIMUS [USP-RS]", "stdName": "SIROLIMUS [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "40d9209d-3223-3a7a-648a-e8e266b4a282" ], "display_name": false }, { "uuid": "01a208c6-65b2-4d4d-b813-191cbc7b0fe6", "name": "SIROLIMUS [VANDF]", "stdName": "SIROLIMUS [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "fe1350aa-8032-499a-9273-e233dac03a33" ], "display_name": false }, { "uuid": "205a2055-83e7-4884-b58f-29e858437da2", "name": "SM-88 COMPONENT SIROLIMUS", "stdName": "SM-88 COMPONENT SIROLIMUS", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "01f5b1dd-34b4-99ee-ce63-e66b120d0703" ], "display_name": false }, { "uuid": "9444aa4f-e045-4db6-8985-e428d2e5bb8d", "name": "Sirolimus", "stdName": "SIROLIMUS", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "55ebbf79-4c31-4567-abab-791f324c4010", "a6ae1e2a-0db9-41e0-9a6b-aaa0b9f2a469", "5cf98eb8-23e4-464c-a94a-a2197c33b6c3", "b9a9b43a-51ca-4f4a-9cba-0a3a951a44f9", "2ca95896-bc2c-4e08-a59b-f34350caead1", "74b19bec-4706-4a76-9ece-1bbf4ab4a225", "42a862a5-82c0-4976-a490-abeada4572fc", "11aeafbf-e543-4aec-9421-f7c7a05ddbf2", "2b4c717b-c5b7-45ed-b39b-9698b2fca01a", "8d5b15d6-6813-4748-bc32-b19332568a36", "d45d2971-9722-4394-8fd6-f2979271ccf3", "76ee5e3f-424c-4987-a8c5-3f14bd3cda73", "76934891-d9b8-450a-828c-2b5a5b026d17", "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "fe1350aa-8032-499a-9273-e233dac03a33", "36eeb0a4-9c4d-4d98-8390-6cbedd8f73d1", "3fa6945f-d253-42ae-bae5-9163062b6d83", "f6c73a97-bdf3-4b53-82bb-bf28f81eb573" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "74e7d102-f9f7-41b8-be47-36646f7b3ee9", "name_org": "INN" }, { "uuid": "f0f96345-70d8-4cdd-a4e5-ea04056d3438", "name_org": "USAN" } ] }, { "uuid": "31a31a4d-4ee9-57cb-2055-b400846e16c0", "name": "Sirolimus [WHO-DD]", "stdName": "SIROLIMUS [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d8350819-00ea-1cc4-c465-cc7f806778c0" ], "display_name": false }, { "uuid": "31e9182b-eb21-4ce4-8ffa-b3b33232e76c", "name": "WY-090217", "stdName": "WY-090217", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "dd8b04d1-e555-4e87-bd9a-52d300bb5b93", "2ca95896-bc2c-4e08-a59b-f34350caead1" ], "display_name": false }, { "uuid": "872a09f6-e6ea-403b-86a5-927bb0be526b", "name": "sirolimus [INN]", "stdName": "SIROLIMUS [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d45d2971-9722-4394-8fd6-f2979271ccf3", "41696263-17ca-4ea8-9372-4f2c1a9e3f25" ], "display_name": false } ], "properties": [ { "uuid": "6ea2e6e8-1061-45a3-b1c5-6ed4a3da43f5", "name": "Biological Half-life", "value": { "uuid": "4cabe611-9ad1-48ff-a54c-576ee2d9d223", "average": 62, "high": 78, "low": 46, "units": "hours" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "5099ccef-01d3-86b4-9943-6390cfa7daf0", "78ae6c72-3610-a303-ead3-dbc8703846a6" ] }, { "uuid": "97485526-b19d-4387-a425-47c42af73c2d", "name": "Tmax", "value": { "uuid": "8f260dbd-ff05-4848-ae5d-08e73111d610", "high": 2, "low": 1, "units": "hours" }, "defining": false, "parameters": [ { "uuid": "abe41d33-9a4b-48f1-b054-39b2e647b01b", "name": "ORAL ADMINISTRATION", "references": [] } ], "property_type": "PHARMACOKINETIC", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ] }, { "uuid": "3dfabe8a-87c9-4d7d-a1ea-e32a0ed2d83b", "name": "Volume of Distribution", "value": { "uuid": "b46c33fc-25d5-466a-8577-118e4ac833c8", "average": 12, "high": 20, "low": 4, "units": "Liters/Kilogram" }, "defining": false, "property_type": "PHARMACOKINETIC", "references": [ "78ae6c72-3610-a303-ead3-dbc8703846a6" ] } ], "modifications": { "uuid": "893ac1de-5015-4a7d-b092-bfd383410c39" } } ] }